FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
31/05/2025
Voltar para busca
Dado oficial do USPTO
ALEVATE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ALEVATE
ST13
US500000079350535Classe
41, 42, 45
Pedido
79350535
Registro
7582839
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
41, 42, 45
Data de depósito
17/05/2022
Data de registro
03/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/12/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
GB
Examinador
PERKINS, ELLEN J
Unidade examinadora
M10
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Sartorius Albumedix Limited
Albumedix Ltd
Representantes
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 41Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 41
Educationclassesseminarsworkshops in the fields of biologymedicinebiologicalsbiopharmaceuticalspharmaceuticalschemical analysis; providing of training in the fields of biologymedicinebiologicalsbiopharmaceuticalspharmaceuticalschemical analysis; teaching and training in the fields of biologymedicinebiologicalsbiopharmaceuticalspharmaceuticals and chemical analysis; teaching and training in the fields of development and use of vaccinesgrowth factorsimmune modulatorsmonoclonal antibodiescellscell therapiestissuesproteinsrecombinant proteinsnucleic acidsgene therapiesproducts derived from living culture systemsproducts derived from human bloodproducts derived from plasma; provision of medicalbiologicalbiopharmaceuticalpharmaceutical and chemical instruction courses; organization of educational conferences in the fields of medicalbiologicalbiopharmaceuticalpharmaceutical and chemical research and development; technical training in the field of medicalbiologicalbiopharmaceuticalpharmaceutical and chemical analysis; informationconsultancy and advisory services for the aforementioned services
Classe 42
Research and development services in the field of new biologicalpharmaceuticalbiopharmaceuticalchemical and medical products; technological consultancyproviding consultancy and expert assistance in the field of new product development of medicines and pharmaceutical productslaboratory analysis in the field of medicines and pharmaceuticals; researchdevelopment and laboratory analysis services relating to pharmaceutical and medicinal goodsin particularalbuminchemicalspeptidesproteinsantibodiescellsnucleic acidsviruseslive viruseslive-attenuated virusesattenuated virusesvirus-like particles and viral vectors; quality management servicesquality evaluation and analysisquality assurancequality control in the field of pharmaceuticalbiopharmaceuticalchemicalmedical products; certificationquality control services in the field of biologicalpharmaceuticalbiopharmaceuticalchemicalmedical products; certificationquality assurance services in the field of biologicalpharmaceuticalbiopharmaceuticalchemicalmedical products; process monitoringquality assurance in the field of biologicalpharmaceuticalbiopharmaceuticalchemicalmedical products; quality control services for others in the field of development and testing of cells; services of a scientific chemical and biological laboratory; development and testing of chemicalpharmaceuticalbiopharmaceuticalchemicalmedical production methods; quality control services for others and authentication services in the field of biologicalpharmaceuticalbiopharmaceuticalchemicalmedical products; process monitoringproviding quality assurance services in the field of biologicalpharmaceuticalbiopharmaceuticalchemicalmedical products; scientific and medical laboratory services; informationconsultancy and advisory services for researchtestingdevelopment in the pharmaceuticalbiopharmaceuticalchemicalmedical fieldsnone of the foregoing related to financial software
Classe 45
Regulatory compliance auditing; regulatory compliance consultancy in the field of biotechnologypharmaceuticalsbiopharmaceuticalsmedical testing and research; reviewing standards and practices to assure compliance with laws and regulations in the fields of biologypharmaceuticalsbiopharmaceuticalschemicalsmedicine; informationconsultancy and advisory services for the aforementioned services
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
25/04/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
25/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/04/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/04/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2024
PUBO
PUBLISHED FOR OPPOSITION
01/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/06/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/06/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
18/03/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
28/02/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
28/02/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
31/12/2023
GNFR
FINAL REFUSAL E-MAILED
31/12/2023
CNFR
FINAL REFUSAL WRITTEN
31/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/11/2023
RFNT
REFUSAL PROCESSED BY IB
24/05/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/05/2023
RFRR
REFUSAL PROCESSED BY MPU
04/05/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/04/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/03/2023
CNRT
NON-FINAL ACTION WRITTEN
15/03/2023
DOCK
ASSIGNED TO EXAMINER
07/03/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
27/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/09/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/09/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALEVATE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.